PSA control following definitive therapy for clinically localized prostate cancer

被引：0
|
作者：
D'Amico, A [1 ]
机构：
[1] Joint Ctr Radiat Therapy, Boston, MA 02215 USA
来源：
MOLECULAR UROLOGY | 1999年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The two goals of treatment for clinically localized prostate cancer are disease control and a good quality of life. At present, the options are radical surgery, conformal or conventional external-beam radiation, and interstitial radiation. This article reviews the effectiveness of these techniques, as judged by serum prostate specific antigen monitoring, with special emphasis on magnetic resonance-guided interstitial brachytherapy.
引用
收藏
页码：207 / 211
页数：5
相关论文
共 50 条
  • [1] PSA AFTER DEFINITIVE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    GOAD, JR
    CHANG, SJ
    OHORI, M
    SCARDINO, PT
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (04) : 727 - 736
  • [2] OVERALL AND CANCER SPECIFIC SURVIVAL FOLLOWING DEFINITIVE THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER IN THE PROSTATE-SPECIFIC ANTIGEN ERA
    Stephenson, Andrew
    Klein, Eric
    Ciezki, Jay
    Reddy, Chandana
    Kattan, Michael
    Yu, Changhong
    Deasy, Joseph
    Michalski, Jeff
    Kallogjeri, Donna
    Lubahn, Jessica
    Luly, Jason
    Piccirillo, Jay
    Kibel, Adam
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E113 - E113
  • [3] Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer
    D'Amico, AV
    [J]. CANCER JOURNAL, 2001, 7 (05): : 375 - 376
  • [4] An analysis of men with clinically localized prostate cancer who deferred definitive therapy
    Patel, MI
    DeConcini, DT
    Lopez-Corona, E
    Ohori, M
    Wheeler, T
    Scardino, PT
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 1520 - 1524
  • [5] The PSA response following radical radiation therapy for localized prostate cancer
    Zietman, AL
    Smith, CT
    Shipley, WU
    [J]. RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 241 - 252
  • [6] The role of androgen deprivation in the definitive management of clinically localized prostate cancer treated with radiation therapy
    Vicini, FA
    Kini, VR
    Spencer, W
    Diokno, A
    Martinez, AA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (04): : 707 - 713
  • [7] Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer
    AV D'Amico
    R Whittington
    SB Malkowicz
    D Schultz
    B Silver
    L Henry
    M Hurwitz
    I Kaplan
    CJ Beard
    JE Tomaszewski
    AA Renshaw
    A Wein
    JP Richie
    [J]. Prostate Cancer and Prostatic Diseases, 2000, 3 : 259 - 264
  • [8] Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Silver, B
    Henry, L
    Hurwitz, M
    Kaplan, I
    Beard, CJ
    Tomaszewski, JE
    Renshaw, AA
    Wein, A
    Richie, JP
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 259 - 264
  • [9] CHANCES IN IMMUNOHISTOCHEMICAL STAINING OF PSA, PAP, AND TURP-27 FOLLOWING IRRADIATION THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    GROB, BM
    SCHELLHAMMER, PF
    BRASSIL, DN
    WRIGHT, GL
    [J]. UROLOGY, 1994, 44 (04) : 525 - 529
  • [10] PREDICTING ALL-CAUSE AND PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING DEFINITIVE THERAPY FOR LOCALIZED PROSTATE CANCER
    Isariyawongse, Brandon
    Stephenson, Andrew
    Kattan, Michael
    Gao, Tianming
    Haslag-Minoff, Jennifer
    Nepple, Kenneth
    Piccirillo, Jay
    Ciezki, Jay
    Klein, Eric
    Kibel, Adam
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E67 - E67
12345